Treatment with leptin downregulates these miRNAs, and hipotalamic silencing of miR-200a increases expression of LEPR and ISR-2 (insulin receptor substrate 2), suggesting that this miRNA can be a target for obesity treatment [48]. The gene discussed is LEP; the disease is obesity disorder.